$CDMO
Avid Bioservices Inc Stock $cdmo

$cdmo Overview Financials Valuation SEC Filings Company Website

2024 Q3 Form 10-Q Financial Statement

#000168316824006262 Filed on September 09, 2024

Income Statement

Concept	2024 Q3
Revenue	$40.17M
YoY Change	6.49%
Cost Of Revenue	$34.46M
YoY Change	2.48%
Gross Profit	$5.713M
YoY Change	39.34%
Gross Profit Margin	14.22%
Selling, General & Admin	$8.169M
YoY Change	30.43%
% of Gross Profit	142.99%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization	$2.824M
YoY Change	6.61%
% of Gross Profit	49.43%
Operating Expenses	$8.169M
YoY Change	30.43%
Operating Profit	-$2.456M
YoY Change	13.55%
Interest Expense	$2.454M
YoY Change	216.65%
% of Operating Profit
Other Income/Expense, Net	-$624.0K
YoY Change	-341.86%
Pretax Income	-$5.534M
YoY Change	106.49%
Income Tax	$0.00
% Of Pretax Income
Net Earnings	-$5.534M
YoY Change	164.41%
Net Earnings / Revenue	-13.78%
Basic Earnings Per Share	-$0.09
Diluted Earnings Per Share	-$0.09
COMMON SHARES
Basic Shares Outstanding	63.64M shares
Diluted Shares Outstanding	63.64M shares

Balance Sheet

Concept	2024 Q3
SHORT-TERM ASSETS
Cash & Short-Term Investments	$33.38M
YoY Change	34.07%
Cash & Equivalents	$33.38M
Short-Term Investments
Other Short-Term Assets	$5.872M
YoY Change	210.36%
Inventory	$29.20M
Prepaid Expenses
Receivables	$20.96M
Other Receivables	$0.00
Total Short-Term Assets	$103.6M
YoY Change	5.39%
LONG-TERM ASSETS
Property, Plant & Equipment	$185.6M
YoY Change	1.82%
Goodwill
YoY Change
Intangibles
YoY Change
Long-Term Investments
YoY Change
Other Assets	$4.664M
YoY Change	-1.96%
Total Long-Term Assets	$231.0M
YoY Change	-32.85%
TOTAL ASSETS
Total Short-Term Assets	$103.6M
Total Long-Term Assets	$231.0M
Total Assets	$334.6M
YoY Change	-24.35%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable	$20.00M
YoY Change	-12.34%
Accrued Expenses	$7.007M
YoY Change	18.18%
Deferred Revenue	$37.66M
YoY Change	14.05%
Short-Term Debt	$0.00
YoY Change
Long-Term Debt Due	$1.472M
YoY Change	173.1%
Total Short-Term Liabilities	$71.08M
YoY Change	10.97%
LONG-TERM LIABILITIES
Long-Term Debt	$160.6M
YoY Change	12.85%
Other Long-Term Liabilities	$43.97M
YoY Change	-3.08%
Total Long-Term Liabilities	$204.6M
YoY Change	8.99%
TOTAL LIABILITIES
Total Short-Term Liabilities	$71.08M
Total Long-Term Liabilities	$204.6M
Total Liabilities	$276.0M
YoY Change	9.64%
SHAREHOLDERS EQUITY
Retained Earnings	-$577.4M
YoY Change	33.38%
Common Stock	$64.00K
YoY Change	1.59%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity	$58.64M
YoY Change
Total Liabilities & Shareholders Equity	$334.6M
YoY Change	-24.35%

Cashflow Statement

Concept	2024 Q3
OPERATING ACTIVITIES
Net Income	-$5.534M
YoY Change	164.41%
Depreciation, Depletion And Amortization	$2.824M
YoY Change	6.61%
Cash From Operating Activities	-$3.680M
YoY Change	1223.74%
INVESTING ACTIVITIES
Capital Expenditures	$1.311M
YoY Change	-90.71%
Acquisitions
YoY Change
Other Investing Activities
YoY Change
Cash From Investing Activities	-$1.311M
YoY Change	-90.71%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities	$266.0K
YoY Change	-64.44%
NET CHANGE
Cash From Operating Activities	-$3.680M
Cash From Investing Activities	-$1.311M
Cash From Financing Activities	$266.0K
Net Change In Cash	-$4.725M
YoY Change	-65.37%
FREE CASH FLOW
Cash From Operating Activities	-$3.680M
Capital Expenditures	$1.311M
Free Cash Flow	-$4.991M
YoY Change	-65.32%

Facts In Submission

Frame	Concept Type	Concept / XBRL Key	Value	Unit
CY2024Q3	dei	Current Fiscal Year End Date CurrentFiscalYearEndDate	--04-30
CY2024Q3	dei	Document Fiscal Year Focus DocumentFiscalYearFocus	2025
CY2024Q3	dei	Document Fiscal Period Focus DocumentFiscalPeriodFocus	Q1
CY2024Q3	dei	Entity Central Index Key EntityCentralIndexKey	0000704562
CY2024Q3	dei	Document Type DocumentType	10-Q
CY2024Q3	dei	Document Quarterly Report DocumentQuarterlyReport	true
CY2024Q3	dei	Document Period End Date DocumentPeriodEndDate	2024-07-31
CY2024Q3	dei	Local Phone Number LocalPhoneNumber	508-6100
CY2024Q3	dei	Security12b Title Security12bTitle	Common Stock, $0.001 par value per share
CY2024Q3	dei	Trading Symbol TradingSymbol	CDMO
CY2024Q3	dei	Security Exchange Name SecurityExchangeName	NASDAQ
CY2024Q3	dei	Entity Current Reporting Status EntityCurrentReportingStatus	Yes
CY2024Q3	dei	Entity Interactive Data Current EntityInteractiveDataCurrent	Yes
CY2024Q3	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	33381000	usd
CY2024Q3	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	20962000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	14209000	usd
CY2024Q3	us-gaap	Inventory Net InventoryNet	29196000	usd
CY2024Q3	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	5872000	usd
CY2024Q3	us-gaap	Assets Current AssetsCurrent	103620000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	185617000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	40741000	usd
CY2024Q2	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q2	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	dei	Entity File Number EntityFileNumber	001-32839
CY2024Q3	dei	Entity Incorporation State Country Code EntityIncorporationStateCountryCode	DE
CY2024Q3	dei	Entity Tax Identification Number EntityTaxIdentificationNumber	95-3698422
CY2024Q3	dei	Entity Address Address Line1 EntityAddressAddressLine1	14191 Myford Road
CY2024Q3	dei	Entity Address City Or Town EntityAddressCityOrTown	Tustin
CY2024Q3	dei	Entity Address State Or Province EntityAddressStateOrProvince	CA
CY2024Q3	dei	Entity Address Postal Zip Code EntityAddressPostalZipCode	92780
CY2024Q3	dei	City Area Code CityAreaCode	714
CY2024Q3	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	us-gaap	Commitments And Contingencies CommitmentsAndContingencies		usd
CY2024Q2	cdmo	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Deferred ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferred	0	shares
CY2024Q3	dei	Document Transition Report DocumentTransitionReport	false
CY2024Q3	dei	Entity Registrant Name EntityRegistrantName	AVID BIOSERVICES, INC.
CY2024Q3	dei	Entity Filer Category EntityFilerCategory	Accelerated Filer
CY2024Q3	dei	Entity Small Business EntitySmallBusiness	false
CY2024Q3	dei	Entity Emerging Growth Company EntityEmergingGrowthCompany	false
CY2024Q3	dei	Entity Shell Company EntityShellCompany	false
CY2024Q3	dei	Entity Common Stock Shares Outstanding EntityCommonStockSharesOutstanding	63795108	shares
CY2024Q2	us-gaap	Cash And Cash Equivalents At Carrying Value CashAndCashEquivalentsAtCarryingValue	38106000	usd
CY2024Q2	us-gaap	Accounts Receivable Net Current AccountsReceivableNetCurrent	16644000	usd
CY2024Q2	us-gaap	Contract With Customer Asset Net ContractWithCustomerAssetNet	12364000	usd
CY2024Q2	us-gaap	Inventory Net InventoryNet	30375000	usd
CY2024Q2	us-gaap	Prepaid Expense And Other Assets Current PrepaidExpenseAndOtherAssetsCurrent	6513000	usd
CY2024Q2	us-gaap	Assets Current AssetsCurrent	104002000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	186514000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41157000	usd
CY2024Q3	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4664000	usd
CY2024Q2	us-gaap	Other Assets Noncurrent OtherAssetsNoncurrent	4884000	usd
CY2024Q3	us-gaap	Assets Assets	334642000	usd
CY2024Q2	us-gaap	Assets Assets	336557000	usd
CY2024Q3	us-gaap	Accounts Payable Current AccountsPayableCurrent	19999000	usd
CY2024Q2	us-gaap	Accounts Payable Current AccountsPayableCurrent	20667000	usd
CY2024Q3	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5608000	usd
CY2024Q2	us-gaap	Employee Related Liabilities Current EmployeeRelatedLiabilitiesCurrent	5437000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	37659000	usd
CY2024Q2	us-gaap	Contract With Customer Liability Current ContractWithCustomerLiabilityCurrent	39887000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1399000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1354000	usd
CY2024Q3	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	6417000	usd
CY2024Q2	us-gaap	Other Liabilities Current OtherLiabilitiesCurrent	3221000	usd
CY2024Q3	us-gaap	Liabilities Current LiabilitiesCurrent	71082000	usd
CY2024Q2	us-gaap	Liabilities Current LiabilitiesCurrent	70566000	usd
CY2024Q3	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	153867000	usd
CY2024Q2	us-gaap	Convertible Subordinated Debt Noncurrent ConvertibleSubordinatedDebtNoncurrent	153593000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43971000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44336000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6725000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7101000	usd
CY2024Q3	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	361000	usd
CY2024Q2	us-gaap	Other Accrued Liabilities Noncurrent OtherAccruedLiabilitiesNoncurrent	72000	usd
CY2024Q3	us-gaap	Liabilities Liabilities	276006000	usd
CY2024Q2	us-gaap	Liabilities Liabilities	275668000	usd
CY2024Q3	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q2	us-gaap	Preferred Stock Par Or Stated Value Per Share PreferredStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Preferred Stock Shares Authorized PreferredStockSharesAuthorized	5000000	shares
CY2024Q3	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q3	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Issued PreferredStockSharesIssued	0	shares
CY2024Q2	us-gaap	Preferred Stock Shares Outstanding PreferredStockSharesOutstanding	0	shares
CY2024Q3	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q2	us-gaap	Preferred Stock Value PreferredStockValue	0	usd
CY2024Q3	us-gaap	Common Stock Par Or Stated Value Per Share CommonStockParOrStatedValuePerShare	0.001
CY2024Q3	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q2	us-gaap	Common Stock Shares Authorized CommonStockSharesAuthorized	150000000	shares
CY2024Q3	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63790000	shares
CY2024Q3	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63790000	shares
CY2024Q2	us-gaap	Common Stock Shares Issued CommonStockSharesIssued	63568000	shares
CY2024Q2	us-gaap	Common Stock Shares Outstanding CommonStockSharesOutstanding	63568000	shares
CY2024Q3	us-gaap	Common Stock Value CommonStockValue	64000	usd
CY2024Q2	us-gaap	Common Stock Value CommonStockValue	64000	usd
CY2024Q3	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	635977000	usd
CY2024Q2	us-gaap	Additional Paid In Capital AdditionalPaidInCapital	632696000	usd
CY2024Q3	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-577405000	usd
CY2024Q2	us-gaap	Retained Earnings Accumulated Deficit RetainedEarningsAccumulatedDeficit	-571871000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	58636000	usd
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	60889000	usd
CY2024Q3	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	334642000	usd
CY2024Q2	us-gaap	Liabilities And Stockholders Equity LiabilitiesAndStockholdersEquity	336557000	usd
CY2024Q3	us-gaap	Revenues Revenues	40173000	usd
CY2023Q3	us-gaap	Revenues Revenues	37726000	usd
CY2024Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	34460000	usd
CY2023Q3	us-gaap	Cost Of Goods And Services Sold CostOfGoodsAndServicesSold	33626000	usd
CY2024Q3	us-gaap	Gross Profit GrossProfit	5713000	usd
CY2023Q3	us-gaap	Gross Profit GrossProfit	4100000	usd
CY2024Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	8169000	usd
CY2023Q3	us-gaap	Selling General And Administrative Expense SellingGeneralAndAdministrativeExpense	6263000	usd
CY2024Q3	us-gaap	Operating Expenses OperatingExpenses	8169000	usd
CY2023Q3	us-gaap	Operating Expenses OperatingExpenses	6263000	usd
CY2024Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2456000	usd
CY2023Q3	us-gaap	Operating Income Loss OperatingIncomeLoss	-2163000	usd
CY2024Q3	us-gaap	Interest Expense InterestExpense	2454000	usd
CY2023Q3	us-gaap	Interest Expense InterestExpense	825000	usd
CY2024Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	-624000	usd
CY2023Q3	us-gaap	Other Nonoperating Income Expense OtherNonoperatingIncomeExpense	258000	usd
CY2024Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-5534000	usd
CY2023Q3	us-gaap	Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest	-2730000	usd
CY2024Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Income Tax Expense Benefit IncomeTaxExpenseBenefit	-608000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5534000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2122000	usd
CY2024Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-5534000	usd
CY2023Q3	us-gaap	Comprehensive Income Net Of Tax ComprehensiveIncomeNetOfTax	-2122000	usd
CY2024Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.09
CY2024Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.09
CY2023Q3	us-gaap	Earnings Per Share Basic EarningsPerShareBasic	-0.03
CY2023Q3	us-gaap	Earnings Per Share Diluted EarningsPerShareDiluted	-0.03
CY2024Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	63639000	shares
CY2024Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	63639000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Shares Outstanding Basic WeightedAverageNumberOfSharesOutstandingBasic	62838000	shares
CY2023Q3	us-gaap	Weighted Average Number Of Diluted Shares Outstanding WeightedAverageNumberOfDilutedSharesOutstanding	62838000	shares
CY2024Q2	us-gaap	Stockholders Equity StockholdersEquity	60889000	usd
CY2024Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	616000	usd
CY2024Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2665000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5534000	usd
CY2024Q3	us-gaap	Stockholders Equity StockholdersEquity	58636000	usd
CY2023Q2	us-gaap	Stockholders Equity StockholdersEquity	189169000	usd
CY2023Q3	us-gaap	Stock Issued During Period Value Share Based Compensation Gross StockIssuedDuringPeriodValueShareBasedCompensationGross	878000	usd
CY2023Q3	us-gaap	Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue	2343000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2122000	usd
CY2023Q3	us-gaap	Stockholders Equity StockholdersEquity	190268000	usd
CY2024Q3	us-gaap	Net Income Loss NetIncomeLoss	-5534000	usd
CY2023Q3	us-gaap	Net Income Loss NetIncomeLoss	-2122000	usd
CY2024Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2824000	usd
CY2023Q3	us-gaap	Depreciation Depletion And Amortization DepreciationDepletionAndAmortization	2649000	usd
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2665000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2343000	usd
CY2024Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	305000	usd
CY2023Q3	us-gaap	Amortization Of Financing Costs AmortizationOfFinancingCosts	339000	usd
CY2024Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	0	usd
CY2023Q3	us-gaap	Deferred Income Tax Expense Benefit DeferredIncomeTaxExpenseBenefit	-620000	usd
CY2024Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-0	usd
CY2023Q3	us-gaap	Gain Loss On Disposition Of Assets GainLossOnDispositionOfAssets	-46000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	4318000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Receivable IncreaseDecreaseInAccountsReceivable	-2089000	usd
CY2024Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	1845000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Asset IncreaseDecreaseInContractWithCustomerAsset	4845000	usd
CY2024Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-1179000	usd
CY2023Q3	us-gaap	Increase Decrease In Inventories IncreaseDecreaseInInventories	-3042000	usd
CY2024Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	-830000	usd
CY2023Q3	us-gaap	Increase Decrease In Prepaid Deferred Expense And Other Assets IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets	131000	usd
CY2024Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	-451000	usd
CY2023Q3	us-gaap	Increase Decrease In Accounts Payable IncreaseDecreaseInAccountsPayable	4684000	usd
CY2024Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	171000	usd
CY2023Q3	us-gaap	Increase Decrease In Employee Related Liabilities IncreaseDecreaseInEmployeeRelatedLiabilities	-4113000	usd
CY2024Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-2228000	usd
CY2023Q3	us-gaap	Increase Decrease In Contract With Customer Liability IncreaseDecreaseInContractWithCustomerLiability	-4333000	usd
CY2024Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	2722000	usd
CY2023Q3	us-gaap	Increase Decrease In Other Current Liabilities IncreaseDecreaseInOtherCurrentLiabilities	736000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-3680000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Operating Activities NetCashProvidedByUsedInOperatingActivities	-236000	usd
CY2024Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	1311000	usd
CY2023Q3	us-gaap	Payments To Acquire Property Plant And Equipment PaymentsToAcquirePropertyPlantAndEquipment	14156000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-1311000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Investing Activities NetCashProvidedByUsedInInvestingActivities	-14156000	usd
CY2024Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	616000	usd
CY2023Q3	us-gaap	Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlans	878000	usd
CY2024Q3	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	350000	usd
CY2023Q3	us-gaap	Repayments Of Other Debt RepaymentsOfOtherDebt	130000	usd
CY2024Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	266000	usd
CY2023Q3	us-gaap	Net Cash Provided By Used In Financing Activities NetCashProvidedByUsedInFinancingActivities	748000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-4725000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Excluding Exchange Rate Effect CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseExcludingExchangeRateEffect	-13644000	usd
CY2024Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38106000	usd
CY2023Q2	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	38892000	usd
CY2024Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	33381000	usd
CY2023Q3	us-gaap	Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents	25248000	usd
CY2024Q3	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	173000	usd
CY2023Q3	us-gaap	Interest Paid Capitalized InterestPaidCapitalized	27000	usd
CY2024Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	31000	usd
CY2023Q3	us-gaap	Income Taxes Paid Net IncomeTaxesPaidNet	12000	usd
CY2024Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	1807000	usd
CY2023Q3	us-gaap	Capital Expenditures Incurred But Not Yet Paid CapitalExpendituresIncurredButNotYetPaid	7636000	usd
CY2024Q3	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	1281000	usd
CY2023Q3	us-gaap	Construction In Progress Expenditures Incurred But Not Yet Paid ConstructionInProgressExpendituresIncurredButNotYetPaid	93000	usd
CY2024Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	40173000	usd
CY2023Q3	us-gaap	Revenue From Contract With Customer Excluding Assessed Tax RevenueFromContractWithCustomerExcludingAssessedTax	37726000	usd
CY2024Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	20500000	usd
CY2023Q3	us-gaap	Contract With Customer Liability Revenue Recognized ContractWithCustomerLiabilityRevenueRecognized	16800000	usd
CY2024Q3	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	0	usd
CY2023Q3	us-gaap	Contract With Customer Asset Cumulative Catch Up Adjustment To Revenue Change In Estimate Of Transaction Price ContractWithCustomerAssetCumulativeCatchUpAdjustmentToRevenueChangeInEstimateOfTransactionPrice	1400000	usd
CY2024Q3	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	1900000	usd
CY2024Q2	us-gaap	Allowance For Doubtful Accounts Receivable AllowanceForDoubtfulAccountsReceivable	2300000	usd
CY2024Q3	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	800000	usd
CY2023Q3	us-gaap	Interest Costs Incurred Capitalized InterestCostsIncurredCapitalized	100000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	225057000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Gross PropertyPlantAndEquipmentGross	223143000	usd
CY2024Q3	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	39440000	usd
CY2024Q2	us-gaap	Accumulated Depreciation Depletion And Amortization Property Plant And Equipment AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment	36629000	usd
CY2024Q3	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	185617000	usd
CY2024Q2	us-gaap	Property Plant And Equipment Net PropertyPlantAndEquipmentNet	186514000	usd
CY2024Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2800000	usd
CY2023Q3	us-gaap	Depreciation And Amortization DepreciationAndAmortization	2600000	usd
CY2024Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2023Q3	us-gaap	Impairment Of Long Lived Assets Held For Use ImpairmentOfLongLivedAssetsHeldForUse	0	usd
CY2024Q3	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	30200000	usd
CY2024Q2	us-gaap	Cash Equivalents At Carrying Value CashEquivalentsAtCarryingValue	27600000	usd
CY2024Q3	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	3400000	usd
CY2024Q2	us-gaap	Marketable Securities Current MarketableSecuritiesCurrent	4400000	usd
CY2024Q3	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	160000000	usd
CY2024Q2	us-gaap	Debt Instrument Face Amount DebtInstrumentFaceAmount	160000000	usd
CY2024Q3	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	6133000	usd
CY2024Q2	us-gaap	Debt Instrument Unamortized Discount Current DebtInstrumentUnamortizedDiscountCurrent	6407000	usd
CY2024Q3	us-gaap	Convertible Debt ConvertibleDebt	153867000	usd
CY2024Q2	us-gaap	Convertible Debt ConvertibleDebt	153593000	usd
CY2024Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1133000	usd
CY2023Q3	us-gaap	Operating Lease Cost OperatingLeaseCost	1140000	usd
CY2024Q3	us-gaap	Variable Lease Cost VariableLeaseCost	463000	usd
CY2023Q3	us-gaap	Variable Lease Cost VariableLeaseCost	351000	usd
CY2024Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	31000	usd
CY2023Q3	us-gaap	Short Term Lease Cost ShortTermLeaseCost	36000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	127000	usd
CY2023Q3	us-gaap	Finance Lease Right Of Use Asset Amortization FinanceLeaseRightOfUseAssetAmortization	54000	usd
CY2024Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	137000	usd
CY2023Q3	us-gaap	Finance Lease Interest Expense FinanceLeaseInterestExpense	27000	usd
CY2024Q3	us-gaap	Lease Cost LeaseCost	1891000	usd
CY2023Q3	us-gaap	Lease Cost LeaseCost	1608000	usd
CY2024Q3	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	40741000	usd
CY2024Q2	us-gaap	Operating Lease Right Of Use Asset OperatingLeaseRightOfUseAsset	41157000	usd
CY2024Q3	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	8984000	usd
CY2024Q2	us-gaap	Finance Lease Right Of Use Asset FinanceLeaseRightOfUseAsset	9270000	usd
CY2024Q3	cdmo	Total Leased Assets TotalLeasedAssets	49725000	usd
CY2024Q2	cdmo	Total Leased Assets TotalLeasedAssets	50427000	usd
CY2024Q3	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1399000	usd
CY2024Q2	us-gaap	Operating Lease Liability Current OperatingLeaseLiabilityCurrent	1354000	usd
CY2024Q3	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1472000	usd
CY2024Q2	us-gaap	Finance Lease Liability Current FinanceLeaseLiabilityCurrent	1450000	usd
CY2024Q3	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	43971000	usd
CY2024Q2	us-gaap	Operating Lease Liability Noncurrent OperatingLeaseLiabilityNoncurrent	44336000	usd
CY2024Q3	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	6725000	usd
CY2024Q2	us-gaap	Finance Lease Liability Noncurrent FinanceLeaseLiabilityNoncurrent	7101000	usd
CY2024Q3	cdmo	Lease Liability LeaseLiability	53567000	usd
CY2024Q2	cdmo	Lease Liability LeaseLiability	54241000	usd
CY2024Q3	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y6M
CY2024Q2	us-gaap	Operating Lease Weighted Average Remaining Lease Term1 OperatingLeaseWeightedAverageRemainingLeaseTerm1	P15Y8M12D
CY2024Q3	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y7M6D
CY2024Q2	us-gaap	Finance Lease Weighted Average Remaining Lease Term1 FinanceLeaseWeightedAverageRemainingLeaseTerm1	P5Y9M18D
CY2024Q3	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2024Q2	us-gaap	Operating Lease Weighted Average Discount Rate Percent OperatingLeaseWeightedAverageDiscountRatePercent	0.060	pure
CY2024Q3	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2024Q2	us-gaap	Finance Lease Weighted Average Discount Rate Percent FinanceLeaseWeightedAverageDiscountRatePercent	0.065	pure
CY2024Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	973000	usd
CY2023Q3	us-gaap	Operating Lease Payments OperatingLeasePayments	1119000	usd
CY2024Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	141000	usd
CY2023Q3	us-gaap	Finance Lease Interest Payment On Liability FinanceLeaseInterestPaymentOnLiability	27000	usd
CY2024Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	350000	usd
CY2023Q3	us-gaap	Finance Lease Principal Payments FinanceLeasePrincipalPayments	130000	usd
CY2024Q3	cdmo	Unpaid Finance Lease Obligation UnpaidFinanceLeaseObligation	263000	usd
CY2023Q3	cdmo	Unpaid Finance Lease Obligation UnpaidFinanceLeaseObligation	0	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal Remainder Of Fiscal Year LongTermDebtMaturitiesRepaymentsOfPrincipalRemainderOfFiscalYear	4529000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Next Twelve Months LongTermDebtMaturitiesRepaymentsOfPrincipalInNextTwelveMonths	6130000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Two LongTermDebtMaturitiesRepaymentsOfPrincipalInYearTwo	5953000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Three LongTermDebtMaturitiesRepaymentsOfPrincipalInYearThree	5370000	usd
CY2024Q3	us-gaap	Long Term Debt Maturities Repayments Of Principal In Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalInYearFour	5481000	usd
CY2024Q3	cdmo	Long Term Debt Maturities Repayments Of Principal After Year Four LongTermDebtMaturitiesRepaymentsOfPrincipalAfterYearFour	54274000	usd
CY2024Q3	cdmo	Long Term Debt Due LongTermDebtDue	81737000	usd
CY2024Q3	cdmo	Less Imputed Interest LessImputedInterest	28170000	usd
CY2024Q3	us-gaap	Long Term Debt LongTermDebt	53567000	usd
CY2024Q3	us-gaap	Common Stock Capital Shares Reserved For Future Issuance CommonStockCapitalSharesReservedForFutureIssuance	7429246	shares
CY2024Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2665000	usd
CY2023Q3	us-gaap	Share Based Compensation ShareBasedCompensation	2343000	usd
CY2024Q3	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	300000	usd
CY2024Q2	us-gaap	Deferred Compensation Liability Current And Noncurrent DeferredCompensationLiabilityCurrentAndNoncurrent	200000	usd
CY2024Q3	cdmo	Share Based Compensation Arrangement By Share Based Payment Award Equity Instruments Other Than Options Vested And Deferred ShareBasedCompensationArrangementByShareBasedPaymentAwardEquityInstrumentsOtherThanOptionsVestedAndDeferred	94961	shares
CY2024Q3	cdmo	Income Tax Expense Benefit1 IncomeTaxExpenseBenefit1	-600000	usd
CY2023Q3	cdmo	Income Tax Expense Benefit1 IncomeTaxExpenseBenefit1	-600000	usd
CY2024Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0	pure
CY2023Q3	us-gaap	Effective Income Tax Rate Continuing Operations EffectiveIncomeTaxRateContinuingOperations	0.22	pure
CY2024Q3	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2024Q2	us-gaap	Income Tax Examination Penalties And Interest Accrued IncomeTaxExaminationPenaltiesAndInterestAccrued	0	usd
CY2024Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	18092000	shares
CY2023Q3	us-gaap	Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount	8821000	shares
CY2024Q3	ecd	Rule10b51 Arr Adopted Flag Rule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Adopted Flag NonRule10b51ArrAdoptedFlag	false
CY2024Q3	ecd	Rule10b51 Arr Trmntd Flag Rule10b51ArrTrmntdFlag	false
CY2024Q3	ecd	Non Rule10b51 Arr Trmntd Flag NonRule10b51ArrTrmntdFlag	false

Files In Submission

Name	View Source	Status
0001683168-24-006262-index-headers.html	Edgar Link	pending
0001683168-24-006262-index.html	Edgar Link	pending
0001683168-24-006262.txt	Edgar Link	pending
0001683168-24-006262-xbrl.zip	Edgar Link	pending
avid_ex3101.htm	Edgar Link	pending
avid_ex3102.htm	Edgar Link	pending
avid_ex3201.htm	Edgar Link	pending
avid_i10q-073124.htm	Edgar Link	pending
cdmo-20240731.xsd	Edgar Link	pending
Financial_Report.xlsx	Edgar Link	pending
MetaLinks.json	Edgar Link	pending
R1.htm	Edgar Link	pending
R10.htm	Edgar Link	pending
R11.htm	Edgar Link	pending
R12.htm	Edgar Link	pending
R13.htm	Edgar Link	pending
R14.htm	Edgar Link	pending
R15.htm	Edgar Link	pending
R16.htm	Edgar Link	pending
R17.htm	Edgar Link	pending
R18.htm	Edgar Link	pending
R19.htm	Edgar Link	pending
R2.htm	Edgar Link	pending
R20.htm	Edgar Link	pending
R21.htm	Edgar Link	pending
R22.htm	Edgar Link	pending
R23.htm	Edgar Link	pending
R24.htm	Edgar Link	pending
R25.htm	Edgar Link	pending
R26.htm	Edgar Link	pending
R27.htm	Edgar Link	pending
R28.htm	Edgar Link	pending
R29.htm	Edgar Link	pending
R3.htm	Edgar Link	pending
R30.htm	Edgar Link	pending
R31.htm	Edgar Link	pending
R32.htm	Edgar Link	pending
R33.htm	Edgar Link	pending
R34.htm	Edgar Link	pending
R35.htm	Edgar Link	pending
R36.htm	Edgar Link	pending
R37.htm	Edgar Link	pending
R38.htm	Edgar Link	pending
R39.htm	Edgar Link	pending
R4.htm	Edgar Link	pending
R40.htm	Edgar Link	pending
R41.htm	Edgar Link	pending
cdmo-20240731_def.xml	Edgar Link	unprocessable
cdmo-20240731_lab.xml	Edgar Link	unprocessable
cdmo-20240731_pre.xml	Edgar Link	unprocessable
FilingSummary.xml	Edgar Link	unprocessable
avid_i10q-073124_htm.xml	Edgar Link	completed
R42.htm	Edgar Link	pending
R43.htm	Edgar Link	pending
R5.htm	Edgar Link	pending
R6.htm	Edgar Link	pending
R7.htm	Edgar Link	pending
R8.htm	Edgar Link	pending
R9.htm	Edgar Link	pending
report.css	Edgar Link	pending
Show.js	Edgar Link	pending
cdmo-20240731_cal.xml	Edgar Link	unprocessable

Create your account

Find Stocks Worth Researching

Deeply Understand Businesses

Value Businesses Intelligently

$CDMO
Avid Bioservices Inc Stock $cdmo

2024 Q3 Form 10-Q Financial Statement

#000168316824006262 Filed on September 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDMO Avid Bioservices Inc Stock $cdmo

2024 Q3 Form 10-Q Financial Statement

#000168316824006262 Filed on September 09, 2024

Income Statement

Balance Sheet

Cashflow Statement

Facts In Submission

Files In Submission

$CDMO
Avid Bioservices Inc Stock $cdmo